SMTL ID : 9ebs.1

Cryo-EM structure of USP1-UAF1-Ubiquitin in complex with TNG348

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-mer

Ligands

1 x 01: 3-(methanesulfonyl)propan-1-amine

01.1: 7 residues within 4Å: Chain A: G.75 Chain C: G.88, N.89, C.91, Q.198, G.593, H.594 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:G.593

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain C: C.441, C.444, C.507, C.510 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:C.441, C:C.444, C:C.507, C:C.510

1 x 02: 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-7-(2,2,2-trifluoroethyl)-7,9-dihydro-8H-purin-8-imine

02.3: 18 residues within 4Å: Chain C: N.85, N.86, N.94, L.97, Q.98, Y.101, F.102, L.160, Q.161, F.164, L.165, T.177, P.179, V.601, Y.744, L.749, S.754, V.756 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:Q.98, C:Y.101, C:F.102 Hydrogen bonds: C:N.86, C:Q.161, C:T.177

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Simoneau, A. et al., Characterization of TNG348: a selective, allosteric USP1 inhibitor that synergizes with PARP inhibitors in tumors with homologous recombination deficiency. Mol.Cancer Ther. (2025)

Release Date

2025-01-29

Peptides

Ubiquitin: A
WD repeat-containing protein 48: B
Ubiquitin carboxyl-terminal hydrolase 1: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
E

Ubiquitin

WD repeat-containing protein 48

Ubiquitin carboxyl-terminal hydrolase 1

Related Entries With Identical Sequence